Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Cramer

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of the National Cancer Institute|July 17, 2003
Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levelsScott D Cramer, Bao-Li Chang, Anuradha Rao, et al.
Molecular Cancer Research : MCR|April 13, 2021
<i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>Lauren K Jillson, Leah C Rider, Lindsey U Rodrigues, et al.
Cancer Research|April 3, 2012
Suppression of Tak1 promotes prostate tumorigenesisMin Wu, Lihong Shi, Adela Cimic, et al.
Biochimica Et Biophysica Acta|September 13, 2005
5-Oxo-ETE analogs and the proliferation of cancer cellsJoseph T O'Flaherty, LeAnn C Rogers, Christian M Paumi, et al.
Carcinogenesis|December 14, 2011
Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancerShihua Wang, Jiansheng Wu, Janel Suburu, et al.
Cancer Research|March 15, 2015
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancerLindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, et al.
Cancer|April 24, 2013
Genetic markers associated with early cancer-specific mortality following prostatectomyWennuan Liu, Chunmei C Xie, Christopher Y Thomas, et al.
Human Molecular Genetics|January 21, 2009
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer riskBao-Li Chang, Scott D Cramer, Fredrik Wiklund, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of the National Cancer Institute|July 17, 2003
Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levelsScott D Cramer, Bao-Li Chang, Anuradha Rao, et al.
Molecular Cancer Research : MCR|April 13, 2021
<i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>Lauren K Jillson, Leah C Rider, Lindsey U Rodrigues, et al.
Cancer Research|April 3, 2012
Suppression of Tak1 promotes prostate tumorigenesisMin Wu, Lihong Shi, Adela Cimic, et al.
Biochimica Et Biophysica Acta|September 13, 2005
5-Oxo-ETE analogs and the proliferation of cancer cellsJoseph T O'Flaherty, LeAnn C Rogers, Christian M Paumi, et al.
Carcinogenesis|December 14, 2011
Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancerShihua Wang, Jiansheng Wu, Janel Suburu, et al.
Cancer Research|March 15, 2015
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancerLindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, et al.
Cancer|April 24, 2013
Genetic markers associated with early cancer-specific mortality following prostatectomyWennuan Liu, Chunmei C Xie, Christopher Y Thomas, et al.
Human Molecular Genetics|January 21, 2009
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer riskBao-Li Chang, Scott D Cramer, Fredrik Wiklund, et al.
Pageof 6